LL-37 is the only cathelicidin peptide made naturally by the human body, a 37 amino acid fragment that white blood cells release at sites of infection and injury. In the laboratory it has been studied for its antimicrobial activity, its role in calming or coordinating the immune response, and its potential to support wound healing. As a therapy it remains research stage: human data is limited and mostly early, so at Menscape Clinic in Bangkok any conversation about LL-37 starts with an honest review of what is and is not yet known.
/)
Medically reviewed by Dr. Tuksaorn Suriyakan (Ping), Anti-Aging & Regenerative Medicine Physician
8 years of experience
Our solutions for Immune & Wellness
Indications evaluated in research, listed in order of current evidence weight. Suitability is determined case-by-case.
LL-37 is the active fragment of human cathelicidin, the only cathelicidin antimicrobial peptide produced by the human body. It is cut from a precursor protein called hCAP18 and released mainly by neutrophils and other immune cells when the body senses infection or tissue damage. Researchers are interested in LL-37 because it appears to do several things at once: it can act directly against microbes in the lab, it helps signal and organize the immune response, and it has been linked in early studies to wound repair processes such as new blood vessel growth. It is important to be clear that most of this understanding comes from cell, animal, and early human research. LL-37 is not an established or approved medicine, and at Menscape Clinic in Bangkok we treat it as an experimental peptide rather than a proven treatment.
/)
LL-37 carries a positive electrical charge, which in laboratory conditions lets it bind to the negatively charged outer membranes of many microbes and disrupt them. Beyond this direct effect, research suggests LL-37 interacts with receptors on human cells to influence immune-cell movement, inflammation, and tissue-repair signaling, including pathways involved in angiogenesis and skin cell growth. The same studies note that its effect on inflammation can run in two directions depending on context, which is one reason its use in autoimmune or chronic-inflammatory conditions is not supported by current evidence. These are proposed mechanisms drawn largely from preclinical work, not confirmed clinical outcomes in patients.
/)
Interest in LL-37 has come from men and others looking into immune support, recovery, and tissue repair, often alongside more established men's-health care. Because the human evidence base is small and early, LL-37 is not appropriate for everyone, and it is not a substitute for antibiotics, vaccines, or treatment of any diagnosed infection or autoimmune condition. It is not suitable for anyone with an active or past cancer concern, given research flagging a possible role in tumor biology, and it is not appropriate during pregnancy or while trying to conceive, given laboratory signals around fertility. At Menscape Clinic in Bangkok, suitability is decided case by case by a doctor after a full medical review.
/)
At Menscape Clinic in Bangkok, LL-37 is only ever discussed within a supervised medical consultation, never sold as an over-the-counter product. Because it is not an approved drug, where a clinician judges it appropriate it would be prescribed off-label and compounded by a licensed pharmacy partner under medical supervision, with a frank discussion of the limited human evidence and the known safety questions. Our doctors review your history, current medications, and goals, set out realistic expectations, and arrange follow-up and monitoring. For many men, the consultation concludes that better-evidenced options are the wiser starting point, and we will say so plainly.
/)
Every LL-37 protocol starts with a full medical consultation and history review.
Prescriptions are filled by a licensed compounding pharmacy partner, not over-the-counter.
Follow-up consultations every four to six weeks to assess response and safety.
We frame LL-37 as a research-stage option and prescribe only when clinically appropriate.
No. LL-37 is not approved by the FDA for any medical use. In the United States it is generally handled as a research compound, and the FDA has specifically cautioned against compounded products containing LL-37 because of limited safety data. Where a clinician judges it appropriate, it may be prescribed off-label and compounded by a licensed pharmacy partner under medical supervision. Regulatory status differs by country, and in Thailand any use would be under a doctor's direction.
The honest answer is that long-term safety in humans is not well established, because the clinical evidence base is small. Research has raised specific cautions, including possible effects on male fertility and a possible role in tumor biology, which is why we do not offer it to men with fertility goals or any cancer history. Any use should only happen under medical supervision after a full review, with monitoring and clear safety boundaries.
In the laboratory and in early research, LL-37 has been studied for antimicrobial activity, immune coordination, biofilm disruption, and tissue repair or wound healing. The most advanced human work so far has been in topical wound healing. These are areas of investigation, not approved or guaranteed uses, and results in people remain preliminary.
It is limited and mostly early. Much of what is known comes from cell and animal studies. Human data is sparse, with the main examples being a published Phase IIb wound-healing trial of an LL-37-based candidate and small exploratory studies. There is not enough evidence to call LL-37 a proven treatment for any condition, and we are transparent about that.
No. Although LL-37 shows antimicrobial activity in laboratory settings, this has not been shown to translate into a reliable infection treatment in people. It should never be used in place of prescribed antibiotics, vaccines, or proper medical care for an active infection. If you have an infection, the right step is a clinical assessment, not an experimental peptide.
Only through a supervised medical consultation. We do not sell it as an over-the-counter supplement. A doctor reviews your history and goals, explains the limited evidence and the known risks, and where appropriate it would be prescribed off-label and compounded by a licensed pharmacy partner, with follow-up and monitoring. In many cases we will recommend better-evidenced options first.
/)
Dr. Tuksaorn (Dr. Ping) is an anti-aging and regenerative medicine physician with over 8 years of experience, focused on evidence-based wellness and personalized health programs that combine modern medical science with individualized care.
/)
/)
/)
/)
/)